Update in Women’s Health 2006–2007

Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.PubMedCrossRefGoogle Scholar

Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12.PubMedCrossRefGoogle Scholar

Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: Scientific review. JAMA. 2004;291:1610–20.PubMedCrossRefGoogle Scholar

Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet. 2000;356:2059–63.PubMedCrossRefGoogle Scholar

Strearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA. 2003;289:2827–34.CrossRefGoogle Scholar

Stearns V, Johnson MD, Rae JM, et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst. 2003;95:1758–64.PubMedGoogle Scholar

Nedrow A, Miller J, Walker M, et al. Complementary and alternative therapies for the management of menopause-related symptoms: A systematic review. Arch Intern Med. 2006;166:1453–65.PubMedCrossRefGoogle Scholar

Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006;98:1204–14.PubMedCrossRefGoogle Scholar

Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371–88.PubMedCrossRefGoogle Scholar

Lin JH, Russell G, Gertz B. Pharmacokinetics of alendronate: an overview. Int J Clin Pract. 1999;101(suppl):18–26.Google Scholar

Bone HG, Hosking D, Devogelaer JP, et al. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350(12):1189–99.PubMedCrossRefGoogle Scholar

Shane E, et al. Osteonecrosis of the jaw: More research needed. J Bone Miner Res. 2006;21(10):1503–05.PubMedCrossRefGoogle Scholar

Stafford RS, Drieling RL, Hersh AL. National trends in osteoporosis visits and osteoporosis treatment, 1988–2003. Arch Intern Med. 2004;164(14):1525–30.PubMedCrossRefGoogle Scholar

ACOG Committee Opinion No. 330. Evaluation and management of abnormal cervical cytology and histology in the adolescent. Obstet Gynecol. 2006;107:963–8Google Scholar

Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481–501.PubMedCrossRefGoogle Scholar

The American College of Obstetrics and Gynecology (ACOG) Practice Bulletin No 73. Contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107:1453–72.Google Scholar

Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mort Wkly Rep Recomm Rep. 2007;56:1–24.Google Scholar

Sexually Transmitted Diseases Treatment Guidelines, 2006. Morb Mort Wkly Rep Recomm Rep. 2006;55:1–94. (Erratum in MMWR Recomm Rep. 2006;55:997).Google Scholar

The American College of Obstetrics and Gynecology (ACOG), Practice Bulletin No. 72. Vaginitis. Obstet Gynecol. 2006;107:1195–206.Google Scholar